Literature DB >> 1570142

Evaluation of the painful total hip arthroplasty.

B G Evans1, J M Cuckler.   

Abstract

Total hip arthroplasty is a common technique for the surgical management of degenerative hip disease. Because of the increasing number of patients and the variety of prostheses and fixation modalities available to the surgeon, the evaluation of the patient with a painful arthroplasty has become an increasingly complex endeavor. The growing number of patients who undergo multiple revision surgeries further complicates the evaluation of the painful arthroplasty. Other complicating factors include the lack of absolute sensitivity and specificity of the variety of diagnostic techniques and the difficulty of differentiating pain caused by septic verses aseptic loosening. This report reviews the recent literature concerning the evaluation of the painful total hip arthroplasty and provides a clinical rationale for the assessment of the painful total hip arthroplasty.

Entities:  

Mesh:

Year:  1992        PMID: 1570142

Source DB:  PubMed          Journal:  Orthop Clin North Am        ISSN: 0030-5898            Impact factor:   2.472


  4 in total

Review 1.  Causes of failure and etiology of painful primary total knee arthroplasty.

Authors:  Romain Seil; Dietrich Pape
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-08-11       Impact factor: 4.342

2.  Painful hip arthroplasty: definition.

Authors:  Paolo Ferrata; Serafino Carta; Mattia Fortina; Daniele Scipio; Alberto Riva; Salvatore Di Giacinto
Journal:  Clin Cases Miner Bone Metab       Date:  2011-05

3.  Pain after total hip arthroplasty: a psychiatric point of view.

Authors:  V Pacault-Legendre; P Anract; M Mathieu; J P Courpied
Journal:  Int Orthop       Date:  2007-10-30       Impact factor: 3.075

4.  Iliopsoas bursa injections can be beneficial for pain after total hip arthroplasty.

Authors:  Ryan M Nunley; Joyce M Wilson; Louis Gilula; John C Clohisy; Robert L Barrack; William J Maloney
Journal:  Clin Orthop Relat Res       Date:  2010-02       Impact factor: 4.176

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.